Home › Funds › EcoR1 Capital, LLC › EIKN

EcoR1 Capital, LLC position in EIKN

EIKON THERAPEUTICS INC · Health Care

EcoR1 Capital, LLC reported holding 855,634 shares of EIKN (EIKON THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 0.33% of its reported portfolio and ranking #26 among its reported holdings. EcoR1 Capital, LLC has disclosed EIKN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)855.63K sh
Reported value held$6.88M
Portfolio Weight0.33%
First reportedQ1 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How EcoR1 Capital, LLC's EIKN position evolved

EcoR1 Capital, LLC first disclosed a stake in EIKN in Q1 2026 at 732,606 shares (US$7.8M). The position peaked in Q2 2026 at 732,606 shares, worth US$9.6M. Across 3 filings, EcoR1 Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 855,634 shares valued at US$6.9M — an increase of 123,028 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 732.61K $7.75M New
Q2 2026 732.61K $9.56M Hold
Q3 2026 855.63K $6.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EIKN and 13F data

EIKN (EIKON THERAPEUTICS INC) is a Health Care company. 100 other funds we track also report a position in EIKN — the largest reported positions include Foresite Capital Management IV, LLC (US$25.4M), Foresite Capital Management V, LLC (US$17.2M), Merck & Co., Inc. (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EIKN

All EIKN fund holders →

FAQ

How long has EcoR1 Capital, LLC held EIKN?

EcoR1 Capital, LLC has disclosed EIKN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is EcoR1 Capital, LLC's current position in EIKN?

As of Q3 2026, EcoR1 Capital, LLC holds 855.63K shares of EIKN (EIKON THERAPEUTICS INC), valued at $6.88M, representing 0.33% of its reported portfolio and ranking #26.

Has EcoR1 Capital, LLC been buying or selling EIKN?

In the latest 13F filing (Q3 2026), EcoR1 Capital, LLC increased its position in EIKN. The position peaked in Q2 2026 at 732.61K shares.

Which other funds hold EIKN?

Other major institutional holders of EIKN include Foresite Capital Management IV, LLC, Foresite Capital Management V, LLC, Merck & Co., Inc., among 100 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.